Results 141 to 150 of about 21,153 (262)

The Clinical Benefits of Nutritional Supplementation Across the Chemotherapy Journey in Cancer Patients: A Multicenter Prospective Cohort Study

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Purpose This study aimed to explore the clinical benefits of receiving nutritional supplementation (NS) throughout the whole course of chemotherapy. Methods This multicenter prospective cohort study totally included 251 cancer patients requiring nutritional support and scheduled for chemotherapy.
Jia‐Xin Huang, Si‐Wei Xie, Hui‐Min Qu, Zhi‐Gang Feng, Xin‐Yi Wang, Jun Zhao, Quan‐Fu Li, Ying Jiang, Feng Chen, Jun Li, Shun‐Chun Yao, Ming‐Hui Zhang, Xian Shen, Xiao‐Dong Chen, Ning Li, Xi Zhang, Le Tian, Min Yang, Meng Tang, Chen‐Xin Song, Bao‐Hua Zou, Sheng‐Ling Qin, Rong Qin, Ming‐Hua Cong   +23 more
wiley   +1 more source

Bladder Cancer Incidence Trends in the United States From 2000 to 2020

Cancer Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Bladder cancer is one of the most common urogenital cancers globally. Here, we aimed to report the incidence trend of bladder cancer in the United States (US) over 2000–2020, by age, sex, race/ethnicity, and types using Surveillance, Epidemiology, and End Results (SEER). Methods We used SEER 22 data to calculate the age‐standardized
Seyed Ehsan Mousavi, Ryan Michael Antar, Armin Aslani, Pourya Shokri, Zahra Yekta, Amin Bateni, Nasser Shakhssalim, Seyed Aria Nejadghaderi   +7 more
wiley   +1 more source

GATA3 is a sensitive marker for primary genital extramammary paget disease: An immunohistochemical study of 72 cases with comparison to gross cystic disease fluid protein 15 [PDF]

, 2017
Cao, Dengfeng, et al,
core   +2 more sources

Spatial Multiomics Reveal Insights Into ADC Efficacy

European Journal of Immunology, Volume 56, Issue 5, May 2026.
Spatial multiomics profiling can reveal how tumor heterogeneity and microenvironment influence ADC efficacy. Combining spatial transcriptomics, proteomics, and AI‐based analysis improves the identification of tissue factors influencing therapy response.
Osman Goni, Niklas Klümper, Maria del Mar Muñiz Moreno, Markus Eckstein, Christoph Kuppe   +4 more
wiley   +1 more source

A Systematic Review and Meta‐Analysis on the Levels of Supportive Care Needs in Adults With Cancer

Psycho-Oncology, Volume 35, Issue 5, May 2026.
ABSTRACT Objective To estimate the levels of supportive care needs among adults with cancer using the Supportive Care Needs Survey–Short Form 34 (SCNS‐SF34) and to examine demographic, clinical, and treatment‐related determinants. Methods A systematic review and meta‐analysis was conducted (CRD42024604977).
Caroline B. Silveira, Anderson Rech, Maria Petropoulou, Pietro S. Rössler, Francine F. de Souza, Helena B. Böhmer, Amanda L. Giacomet, Richard Alejandro B. de Barros, Lucélia de C. de Barros, Vagner R. Z. B. Pereira, Nanci da S. T. Junqueira, Pedro Lopez   +11 more
wiley   +1 more source

Proximal ureteral fibroepithelial polyp with secondary renal atrophy in a dog (Canis lupus familiaris)

Veterinary Record Case Reports, Volume 14, Issue 2, May 2026.
Abstract A 12‐year‐old, male intact, Papillon dog was presented following trauma from a motor vehicle accident. On arrival, the dog was laterally recumbent with neurological dysfunction (modified Glasgow coma scale 12) and multiple injuries, including right hip luxation and suspected haemorrhage.
Charles T. Talbot, Xiaobo Wang, Ji‐Hang Yin   +2 more
wiley   +1 more source

Integumentary fibrosarcoma in a free‐living swan (Cygnus olor): Medical and welfare considerations

Veterinary Record Case Reports, Volume 14, Issue 2, May 2026.
Abstract A 10‐kg adult male mute swan (Cygnus olor) of unknown age was admitted for investigations of two large ventral masses overlying the keel bone, which were discharging purulent material. The masses measured 8.9 × 2.1 cm and 4.2 × 3.2 cm. Empirical treatment with non‐steroidal anti‐inflammatory drugs and antimicrobials was instigated.
Rachael Amy McKinney, Katherine Hughes
wiley   +1 more source

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

British Journal of Pharmacology, Volume 183, Issue 9, Page 1779-1813, May 2026.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos, Stavros Topouzis, Steve P. H. Alexander, Miriam M. Cortese‐Krott, Zsuzsanna Helyes, Kirill Martemyanov, Claudio Mauro, Nithyanandan Nagercoil, Reynold A. Panettieri Jr, Hemal H. Patel, Rainer Schulz, Barbara Stefanska, Gary J. Stephens, Nathalie Vergnolle, Xin Wang, Stephen Ward, Péter Ferdinandy   +16 more
wiley   +1 more source

Health‐related quality of life and functional outcomes of colon cancer patients in the Netherlands: A population‐based study

Colorectal Disease, Volume 28, Issue 5, May 2026.
Abstract Background Colon cancer treatment has evolved significantly through earlier detection, less invasive surgery, optimised perioperative care and shortening chemotherapy duration from 6 to 3 months in 2017. These multidisciplinary improvements may contribute to better health‐related quality of life (HRQoL), yet population‐based data on their real‐
A. J. Pennings, G. R. Vink, S. van Kuijk, M. Koopman, J. Melenhorst, G. L. Beets, A. M. May, S. O. Breukink   +7 more
wiley   +1 more source

Urogenital Cancers: New Molecular and Translational Aspects on Carcinogenesis and Treatments. [PDF]

Biomedicines
Perri A, Rago V, Di Agostino S.
europepmc   +1 more source